Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Travel Awards - Institute Community Support

University of Toronto

$1,000.00

Identification of Epstein-Barr Virus Proteins that Modulate Cellular SUMO modification pathways

FY 2017-18

Summary
Most people are infected with three different herpesviruses; herpes simplex virus 1 (HSV-1), cytomegalovirus (CMV) and Epstein-Barr virus (EBV). These life-long infections can be asymptomatic or can lead to a variety of health problems including oral lesions, mononucleosis, cancer and life-threatening illnesses in immune suppression. EBV is a particular health problem as it induces a variety of lymphomas and carcinomas, resulting in ~200,000 new cancer cases and ~140,000 deaths per year. Herpesviruses persist and cause disease through the action of the numerous proteins that they encode, which bind to and manipulate the functions of some cellular proteins. However the functions and cellular targets of most of the viral proteins have not yet been determined. The activities of many cellular proteins are controlled by SUMO modifications, so viruses can affect cellular processes by altering these modifications. This project uses comprehensive methods to elucidate how EBV proteins manipulate cellular SUMO pathways as well as related proteins in HSV-1 and CMV. The cellular proteins targeted by these viral proteins and their significance for viral infection and cellular processes will also be determined. This work will provide insight into how viruses manipulate cells to enable life-long persistence and cause disease. It will also identify cellular proteins that play important roles in various cellular processes that are altered by viral infection, and mechanisms of regulation of these processes. Finally, the viral-host interactions discovered in this project will provide potential drug targets for antiviral treatments.
Program
Travel Awards - Institute Community Support
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
368463
Name
de la Cruz Herrera Carlos F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Institute of Cancer Research
Projecttitle
Identification of Epstein-Barr Virus Proteins that Modulate Cellular SUMO modification pathways
Programtype2
Undefined
Orgnameinp2
University of Toronto
Cihramount2
$1,000
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Ics Travel Awards
Abstract
Most people are infected with three different herpesviruses; herpes simplex virus 1 (HSV-1), cytomegalovirus (CMV) and Epstein-Barr virus (EBV). These life-long infections can be asymptomatic or can lead to a variety of health problems including oral lesions, mononucleosis, cancer and life-threatening illnesses in immune suppression. EBV is a particular health problem as it induces a variety of lymphomas and carcinomas, resulting in ~200,000 new cancer cases and ~140,000 deaths per year. Herpesviruses persist and cause disease through the action of the numerous proteins that they encode, which bind to and manipulate the functions of some cellular proteins. However the functions and cellular targets of most of the viral proteins have not yet been determined. The activities of many cellular proteins are controlled by SUMO modifications, so viruses can affect cellular processes by altering these modifications. This project uses comprehensive methods to elucidate how EBV proteins manipulate cellular SUMO pathways as well as related proteins in HSV-1 and CMV. The cellular proteins targeted by these viral proteins and their significance for viral infection and cellular processes will also be determined. This work will provide insight into how viruses manipulate cells to enable life-long persistence and cause disease. It will also identify cellular proteins that play important roles in various cellular processes that are altered by viral infection, and mechanisms of regulation of these processes. Finally, the viral-host interactions discovered in this project will provide potential drug targets for antiviral treatments.
Competitiondate
201707
Approvedterm2
1 yr 0 mth
Pinamesdelim
de la Cruz Herrera, Carlos F
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $1,000~ $0~